KRAS-targeted vaccine
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for KRAS-targeted vaccine, covering 2025-12-18 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer [Phase 1]